Atıf Formatları
The relationship between eGFR and capecitabine efficacy/toxicity in metastatic breast cancer
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. Celik Et Al. , "The relationship between eGFR and capecitabine efficacy/toxicity in metastatic breast cancer," Medical Oncology , vol.38, no.1, 2021

Celik, E. Et Al. 2021. The relationship between eGFR and capecitabine efficacy/toxicity in metastatic breast cancer. Medical Oncology , vol.38, no.1 .

Celik, E., Samanci, N. S., KARADAĞ, M., DEMİRCİ, N. S., Demirelli, F. H., & ÖZGÜROĞLU, M., (2021). The relationship between eGFR and capecitabine efficacy/toxicity in metastatic breast cancer. Medical Oncology , vol.38, no.1.

Celik, Emir Et Al. "The relationship between eGFR and capecitabine efficacy/toxicity in metastatic breast cancer," Medical Oncology , vol.38, no.1, 2021

Celik, Emir Et Al. "The relationship between eGFR and capecitabine efficacy/toxicity in metastatic breast cancer." Medical Oncology , vol.38, no.1, 2021

Celik, E. Et Al. (2021) . "The relationship between eGFR and capecitabine efficacy/toxicity in metastatic breast cancer." Medical Oncology , vol.38, no.1.

@article{article, author={Emir Celik Et Al. }, title={The relationship between eGFR and capecitabine efficacy/toxicity in metastatic breast cancer}, journal={Medical Oncology}, year=2021}